Stay updated on Etrasimod in Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Etrasimod in Ulcerative Colitis Clinical Trial page.

Latest updates to the Etrasimod in Ulcerative Colitis Clinical Trial page
- Check3 days agoChange Detected- Updates the citation entry for a specific PubMed-derived publication about non-serious adverse events in ulcerative colitis patients receiving etrasimod. - Updates the ClinicalTrials.gov page revision/build label from v3.5.0 to v3.5.3.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check74 days agoChange DetectedThe changes consist of a minor revision update (Revision: v3.4.2 added; Revision: v3.4.1 deleted) with no visible impact on study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision: v3.4.1 appears as a minor version update replacing v3.4.0, with no visible changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check96 days agoChange DetectedShow glossary option added; capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'; revision updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Etrasimod in Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Etrasimod in Ulcerative Colitis Clinical Trial page.